Caribou Biosciences, Inc.
CRBU
$0.735
$0.00190.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -46.08% | -56.65% | -11.01% | -6.35% | -2.66% |
| Total Depreciation and Amortization | 11.40% | 5.83% | 79.69% | 91.59% | 117.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.82% | 140.76% | 49.46% | 38.92% | 13.91% |
| Change in Net Operating Assets | 30.12% | 133.78% | -269.06% | -298.15% | -74.07% |
| Cash from Operations | -48.14% | -28.01% | -32.79% | -5.47% | -2.56% |
| Capital Expenditure | 57.98% | 40.15% | -39.29% | -42.10% | -79.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 261.70% | 287.52% | -239.58% | -849.69% | 34.82% |
| Cash from Investing | 227.02% | 210.31% | -326.82% | -14,918.22% | 26.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.16% | -91.67% | 638.95% | 5,831.20% | 7,135.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -89.16% | -91.70% | 638.73% | 5,829.66% | 7,133.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -385.91% | -428.08% | 38.35% | 96.48% | 96.06% |